




CLASSIFICATION: GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: TIRZEPATIDE
FORM: POWDER - 2 ML VIAL x 5 MG/VIAL
ACTIVE HALF-LIFE: 5 DAYS
DOSAGE: 2.5 - 5 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA, EUROPE
LABORATORY TESTED: VIEW LAB RESULTS
DragonPharma.net online store sells anabolic steroids, we have only original anabolic steroids, you can buy from us original Tirzepatide by Dragon Pharma.
Tirzepatide is a novel and investigational medication belonging to the class of drugs known as dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists. Developed for the treatment of type 2 diabetes, Tirzepatide combines the actions of both GIP and GLP-1 to enhance glycemic control.
Tirzepatide is primarily used for managing hyperglycemia in individuals with type 2 diabetes. As a dual GIP and GLP-1 receptor agonist, it stimulates the release of insulin while suppressing the secretion of glucagon, leading to improved glucose regulation.
Dosage recommendations for Tirzepatide can vary and are typically determined by healthcare professionals based on individual patient needs. The medication is administered through subcutaneous injections, and the frequency of dosing may depend on the specific formulation prescribed.
Common side effects of Tirzepatide may include nausea, vomiting, diarrhea, and injection-site reactions. Serious side effects are rare but can include pancreatitis and hypoglycemia. It is crucial for individuals using Tirzepatide to be aware of potential side effects and promptly report any concerns to their healthcare provider.
Important Considerations:
Tirzepatide represents a significant advancement in the pharmacological management of type 2 diabetes. As with any medication, individuals should rely on healthcare professionals for guidance, and open communication about any concerns or side effects is essential for safe and effective use.
Tirzepatide, being a medication for diabetes management, does not involve post-cycle therapy as seen in the context of anabolic steroid cycles. Instead, individuals are advised to follow their healthcare provider's guidance for ongoing diabetes management, including regular monitoring of blood glucose levels.
Unlike traditional performance-enhancing cycles, Dragon Pharma Tirzepatide is not used in a cyclical pattern. It is prescribed as a long-term treatment to maintain glycemic control in individuals with type 2 diabetes. The treatment duration is generally continuous, with adjustments made by healthcare providers as needed.
Despite that it is extremely safe, you should not exceed the recommended dosages.
Please log in to write TIRZEPATIDE review.
CLASSIFICATION: GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: SEMAGLUTIDE
FORM: POWDER - 2 ML VIAL x 5 MG
ACTIVE HALF-LIFE: 7 DAYS
DOSAGE: 0.25 - 0.5 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA, EUROPE
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: GIP/GLP-1/GLUCAGON RECEPTOR TRIAGONIST
ACTIVE SUBSTANCE: RETATRUTIDE
FORM: 2 ML VIAL x 10 MG
ACTIVE HALF-LIFE: ~ 6 DAYS
DOSAGE: 0.5 MG/WEEK
ACNE: N/A
WATER RETENTION: N/A
HBR: N/A
HEPATOTOXICITY: N/A
AROMATIZATION: N/A
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: HUMAN PEPTIDE HORMONE
ACTIVE SUBSTANCE: EPHITALON ACETATE
FORM: 2 ML VIAL x 50 MG
ACTIVE HALF-LIFE: N/A
DOSAGE: MEN 5 MG-10 MG PER DAY
ACNE: NOT REPORTED
WATER RETENTION: MINIMAL
HBR: N/A
HEPATOTOXICITY: N/A
AROMATIZATION: N/A
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
Jan 19, 2025 (14:05)
This supplement keeps me feeling full longer, and my metabolism has improved. Tirzepatide makes weight loss simple.